LIG4 and plasma cell myeloma: In 2002, Kuschel et al.40 found that LIG4 D501D polymorphism was associated with a decrease in breast cancer risk and Roddam et al.42 found that LIG4 T9I polymorphism may modulate predisposition to multiple myeloma.